NOS2 and neoplasm: However, the TNBC patients with increased iNOS expression (from negative to positive and from grade 1+ to 2+) and unchanged iNOS expression showed an average of 59.35% tumor reduction, which is significantly lower than attenuated iNOS expression group (p< 0.01) (Fig 3).